AzTrials
AzTrials

Rolandic EpilepsyNCT01046760

Scholar Performance and Praxis Assessment in Children With Rolandic Epilepsy

An observational study of Rolandic Epilepsy and Apraxia, run by University of Campinas, Brazil at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Rolandic Epilepsy is the most common form of childhood epilepsy. It is classified as idiopathic, age-related epilepsy syndrome with benign evolution. The absence of neuropsychological impairment is part of the criteria of benignity of this epilepsy syndrome. Read more about this study

Who is it for?
Ages 7 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Rolandic Epilepsy, Apraxia
What is being tested?
Language Assessment
How many people
20 participants
Where
1 siteBrazil
Study dates
Sep 2009to Feb 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Amongst patients with rolandic epilepsy assisted at the Clinic of Neurological-Psychological-Language in childhood of Hospital de Clínicas of Universidade Estadual de Campinas (Unicamp).

Who may be able to join

  • Diagnosis of rolandic epilepsy using clinical, EEG and neuroimaging findings
  • Patients had neurological, ophthalmic and auditory unchanged, and intelligence quotient (IQ) equal to or above 80.
  • All parents signed the consent form, authorizing the participation of their children (as) in the search.

Who cannot join

  • With oral language and writing of the following tables, whereas the DSM-IV: pervasive developmental disorders, cerebral palsy child acquired aphasia, hearing impairment (including mild conductive hearing loss), progressive disease
  • What not signed the consent form.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Clinical Hospital

    Campinas, São Paulo, 13041317

Other trials in Brazil

About this study

Rolandic Epilepsy is the most common form of childhood epilepsy. It is classified as idiopathic, age-related epilepsy syndrome with benign evolution. The absence of neuropsychological impairment is part of the criteria of benignity of this epilepsy syndrome. However recently have been suggested several deficits related to attention and language. The purpose of this study was assess school performance and to investigate problems of praxis in patients with rolandic epilepsy as compared to a control group composed of normal children with age, gender and educational level equivalents.

Read the detailed description

Method: Nineteen patients aged between 7 and 12 years underwent clinical neurological evaluation, psychological assessment, through Weschsler Scales of Intelligence and language evaluation, to assess the academic performance and research of the presence or absence of praxis difficulties.

Being tested
Language Assessment
Keywords
epilepsy, language, childhood, praxis
Medical subject headings
Epilepsy, Rolandic, Apraxias, Epilepsy, Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Language AssessmentBehavioural

    Also called Children with epilepsy, language impairment and dyslexia

    Patients underwent an assessment performed with School Performance Test, Syntactic Awareness Test and a Peabody Picture Vocabulary Test.

Study groups in NCT01046760
Study groupRoleWhat they receive
Rolandic EpilepsyPatients older than seven years old with clinical and electroencephalographic diagnosis of Rolandic Epilepsy
Receives: Behavioral: Language Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Our data will indicate the group performance in tests of writing, arithmetic and reading.

    Measured: one year

Secondary outcomes (1)
  1. Another important aspect was the absence of orofacial apraxia in children with epilepsy.

    Measured: one year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2010 (estimated)
  2. Study startSep 2009
  3. Primary completionFeb 2011 (estimated)
  4. Study completionFeb 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01046760
Sponsor's protocol ID
21 CFR 50.3.
Status last verified
Oct 2010
First submitted
11 Jan 2010
Last updated
20 Oct 2010
Results posted
No
Data monitoring committee
Yes

Publications

  • Oliveira EP, Neri ML, Medeiros LL, Guimaraes CA, Guerreiro MM. School performance and praxis assessment in children with Rolandic Epilepsy. Pro Fono. 2010 Jul-Sep;22(3):209-14. doi: 10.1590/s0104-56872010000300009. English, Portuguese.

    PubMed 21103707

Questions about this trial

What is this clinical trial studying?

An observational study of Rolandic Epilepsy and Apraxia, run by University of Campinas, Brazil at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 20 Oct 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Our data will indicate the group performance in tests of writing, arithmetic and reading. (time frame: one year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01046760, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in